![Christopher Sarchi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Sarchi
Corporate Officer/Principal bei
REPLIMUNE GROUP, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Christopher Sarchi is currently Chief Commercial Officer at Bicara Therapeutics, Inc. since 2026 and Chief Commercial Officer at Replimune Group, Inc. since 2022.
Former positions include Director-Oncology Regional Sales at Genentech, Inc. from 2010 to 2013 and Head-Commercial Oncology US Region at Sanofi.
Education includes undergraduate studies at the University of Maine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPLIMUNE GROUP, INC. 0,23 % | 01.06.2026 | 180.962 ( 0,23 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Christopher Sarchi
| Unternehmen | Position | Beginn |
|---|---|---|
| REPLIMUNE GROUP, INC. | Corporate Officer/Principal | 01.12.2022 |
| BICARA THERAPEUTICS INC. | Corporate Officer/Principal | 08.05.2026 |
Ehemalige bekannte Positionen von Christopher Sarchi
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.01.2013 |
| SANOFI | Corporate Officer/Principal | - |
Ausbildung von Christopher Sarchi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
